Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

I maintain a 70% allocation to SPY and 30% to EFA, as both are in bullish uptrends above their 10-month EMAs. Learn more ...

The S&P 500 slipped back below its 50-day moving average to end the week, marking the index's seventh cross of the key ...

Brighton manager Fabian Hurzeler speaking to Sky Sports: "We wanted to create a desire to defend and create an energy on the pitch that brings the whole stadium behind us and I think we did that in ...

Australia's Lendlease hits near four‑decade low after swinging to first‑half loss Australia's Lendlease Group swung to a first-half loss on Monday, pressured by impairments and a fall in the valuation ...

European shares close eighth month of gains on earnings lift; credit fears hit banks European shares closed at a record high on Friday to log their eighth straight month of gains after ...

Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...

Cybersecurity attacks are now a common fixture of the digital landscape, but not enough people take password security seriously. Testing your password strength is one of the most overlooked yet vital ...

Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.